
Cardiomatics is an advanced healthcare technology platform specializing in automated long-term ECG analysis powered by artificial intelligence. Designed to support cardiac clinics, service providers, and general practitioners, Cardiomatics aims to scale up cardiac care through precise, rapid, and economical ECG diagnostics. At the heart of its offering is AI-driven software that processes long-term ECG signals from Holters and ECG patches, enabling clinicians to make informed decisions within minutes rather than hours. Cardiomatics emphasizes both accuracy and speed in cardiac diagnostics, promising to reduce the time required for handling ECG data by up to 80% compared to traditional manual methods. This contributes to improved clinical workflow efficiency, enhanced patient satisfaction, and increased service capacity for practices operating with limited resources. Fundamental to Cardiomatics’ technology is its status as a CE-marked medical device, reflecting compliance with European regulatory standards for health and safety in medical software. The platform has harnessed proprietary algorithms, validated in clinical trials, which have processed over 8 million hours of ECG recordings. This substantial data volume underpins the reliability and effectiveness of Cardiomatics’ diagnostic outputs. Reports generated using the platform are described as comprehensive and tailored to the core clinical needs of cardiac professionals, as evidenced by a customer feedback metric showing that 96% of Cardiomatics ECG analysis reports successfully addressed the essential requirements for cardiac diagnostics. The platform offers a web-based, device-independent solution, compatible with over 40 common ECG recorders. Its interface is noted for intuitive navigation and straightforward report generation, allowing clinicians to integrate Cardiomatics quickly into routine practice without significant additional training. Cardiomatics’ long-term ECG reports are presented in an easy-to-read format, fostering rapid clinical interpretation and timely decision making. Testimonials from cardiology teams across France, Switzerland, and Poland highlight Cardiomatics’ impact on day-to-day practice, citing the streamlined experience and the platform’s ability to save valuable medical time. These endorsements also reinforce the solution’s usability, reliability, and positive influence on patient throughput.
Cardiomatics distinguishes itself in the cardiac diagnostics market by leveraging a combination of advanced AI-driven ECG analysis, robust regulatory compliance, broad device compatibility, and referenceable clinical efficacy. Its most notable competitive edge lies in the automation of long-term ECG interpretation, dramatically accelerating clinical workflows and optimizing resource allocation in cardiac clinics. Unlike many competitors that rely primarily on manual review or less sophisticated algorithmic approaches, Cardiomatics employs CE-marked medical device algorithms validated through clinical trials and real-world usage, having processed over eight million hours of ECG recordings. This yields high confidence in both the accuracy and speed of its analysis, with the company claiming up to 80% time reduction for long-term ECG evaluation compared to manual processes. Another key differentiator is its truly device-independent architecture. Cardiomatics is compatible with more than 40 ECG recorders and patches, enabling seamless adoption and integration into diverse clinical environments without requiring investment in new hardware. This expansive compatibility sets Cardiomatics apart from platforms restricted to select hardware or proprietary devices, thus appealing to clinics with existing equipment and established workflows. The web-based, user-friendly interface further reinforces usability, ensuring a fast learning curve for clinicians and minimal friction in onboarding. This is crucial in a field where time is clinical currency and ease of use can be a decisive factor for adoption.
البائع
Cardiomatics Inc.
موقع المقر الرئيسي
Krakow, Poland
الموقع الإلكتروني للشركة
https://www.cardiomatics.com
التواصل
+1 536917640
سنة التأسيس
2017
البريد الإلكتروني
Real-time ECG analysis
Arrhythmia detection
Personalized health insights
Remote monitoring capabilities
AI-powered algorithms
User-friendly interface
Health trend tracking
Mobile application support
English
Danish
French
Where does Cardiomatics have offices in GCC?
Not available.
Who are Cardiomatics customers in the Middle East?
Not available.
What is Cardiomatics local address?
Not available.
Is CardiomaticsPlatform available in Arabic?
Not available.
Does Cardiomatics platform use AI? And where?
Cardiomatics platform uses AI, specifically in ECG (electrocardiogram) analysis and clinical diagnostics.
ECG Signal Analysis: Cardiomatics leverages advanced machine learning algorithms to automatically interpret long-term ECG signals from Holter monitors and wearable ECG patches, identifying arrhythmias and generating rapid, clinically validated diagnostic reports.
Automated Detection of Atrial Fibrillation and Abnormalities: Its AI-driven technology is validated for the accurate assessment of atrial fibrillation burden and other cardiac rhythm disorders, often matching the precision of manual review while reducing analysis time by up to 80%.
Cloud-based Diagnostics and Workflow: Cardiomatics applies AI algorithms as a SaaS cloud service, allowing device-independent analysis and compatibility with over 40 ECG recorders. The platform processes millions of hours of ECG data to continually improve the accuracy of predictive models.
Clinical Trial Validation: Cardiomatics AI has been validated in peer-reviewed clinical trials for accuracy, effectiveness, and reliability in day-to-day clinical practice.
Is Cardiomatics a Web3 company?
No.
Are there any Web3 components in Cardiomatics?
No.
Request a quote
احصل على أقصى استفادة من المراجعات؛
الاستفادة من قوة الذكاء الاصطناعي لتحقيق النجاح!
ما هو Cardiomatics من حيث القيمة مقابل المال؟
بالنسبة لشركتي التي تضم 10000 موظفما هو Cardiomatics من حيث سهولة الاستخدام؟
بالنسبة لشركتي التي تضم 10000 موظف